| Primary |
| Glaucoma |
31.3% |
| Eye Operation |
15.6% |
| Eye Inflammation |
10.9% |
| Anaemia |
6.3% |
| Atrial Fibrillation |
6.3% |
| Constipation |
6.3% |
| Developmental Glaucoma |
4.7% |
| Dilatation Pupillary |
3.1% |
| Intraocular Pressure Increased |
3.1% |
| Anesthesia Local |
1.6% |
| Cerebrovascular Accident |
1.6% |
| Drug Use For Unknown Indication |
1.6% |
| Intraocular Pressure Test Abnormal |
1.6% |
| Medical Observation |
1.6% |
| Open Angle Glaucoma |
1.6% |
| Product Used For Unknown Indication |
1.6% |
| Visual Acuity Reduced |
1.6% |
|
| Uveitis |
14.8% |
| Hypersensitivity |
11.1% |
| Nephropathy Toxic |
7.4% |
| Ocular Hyperaemia |
7.4% |
| Renal Impairment |
7.4% |
| Blindness Transient |
3.7% |
| Blood Pressure Increased |
3.7% |
| Dermatitis Atopic |
3.7% |
| Dizziness |
3.7% |
| Fall |
3.7% |
| Laryngitis |
3.7% |
| Optic Atrophy |
3.7% |
| Paraesthesia |
3.7% |
| Pruritus |
3.7% |
| Skin Irritation |
3.7% |
| Stupor |
3.7% |
| Symblepharon |
3.7% |
| Visual Acuity Reduced |
3.7% |
| Visual Field Defect |
3.7% |
|
| Secondary |
| Glaucoma |
33.8% |
| Intraocular Pressure Increased |
13.8% |
| Developmental Glaucoma |
10.0% |
| Eye Operation |
7.5% |
| Hypertension |
6.3% |
| Eye Inflammation |
5.0% |
| Emphysema |
3.8% |
| Eye Disorder |
3.8% |
| Cystoid Macular Oedema |
2.5% |
| Anticoagulant Therapy |
1.3% |
| Blood Cholesterol Increased |
1.3% |
| Constipation |
1.3% |
| Diuretic Therapy |
1.3% |
| Diverticulitis |
1.3% |
| Dry Eye |
1.3% |
| Dyspepsia |
1.3% |
| Eye Pruritus |
1.3% |
| Gastric Disorder |
1.3% |
| Hepatic Steatosis |
1.3% |
| Insomnia |
1.3% |
|
| Hypersensitivity |
7.7% |
| Intraocular Pressure Test Abnormal |
7.7% |
| Ocular Hyperaemia |
7.7% |
| Tachycardia |
7.7% |
| Visual Acuity Reduced |
7.7% |
| Vitreous Haemorrhage |
7.7% |
| Corneal Transplant |
3.8% |
| Depressed Level Of Consciousness |
3.8% |
| Eye Irritation |
3.8% |
| Hypertension |
3.8% |
| Medication Error |
3.8% |
| Optic Nerve Injury |
3.8% |
| Optic Neuropathy |
3.8% |
| Respiratory Arrest |
3.8% |
| Respiratory Tract Inflammation |
3.8% |
| Restlessness |
3.8% |
| Retinal Detachment |
3.8% |
| Toxicity To Various Agents |
3.8% |
| Ulcerative Keratitis |
3.8% |
| Vision Blurred |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.2% |
| Glaucoma |
16.2% |
| Drug Use For Unknown Indication |
9.4% |
| Adverse Event |
5.1% |
| Chronic Obstructive Pulmonary Disease |
4.8% |
| Atrial Fibrillation |
4.6% |
| Hypertension |
4.6% |
| Gastrooesophageal Reflux Disease |
2.8% |
| Pain |
2.8% |
| Type 2 Diabetes Mellitus |
2.3% |
| Prophylaxis |
2.2% |
| Asthma |
1.6% |
| Diabetes Mellitus |
1.6% |
| Eye Disorder |
1.6% |
| Blood Cholesterol Increased |
1.5% |
| Hypothyroidism |
1.4% |
| Plasma Cell Myeloma |
1.4% |
| Rheumatoid Arthritis |
1.4% |
| Uveitis |
1.4% |
| Constipation |
1.1% |
|
| Myositis |
13.6% |
| Tremor |
7.8% |
| Drug Ineffective |
6.8% |
| Systemic Inflammatory Response Syndrome |
6.8% |
| Visual Field Defect |
6.8% |
| Glaucoma |
5.8% |
| Therapeutic Response Unexpected |
5.8% |
| Vomiting |
5.8% |
| Visual Acuity Reduced |
4.9% |
| Visual Impairment |
4.9% |
| White Blood Cell Count Increased |
4.9% |
| Eye Disorder |
3.9% |
| Upper Respiratory Tract Infection |
3.9% |
| Vision Blurred |
3.9% |
| Malaise |
2.9% |
| Pain |
2.9% |
| Thrombocytopenia |
2.9% |
| Atrial Fibrillation |
1.9% |
| Clostridium Difficile Sepsis |
1.9% |
| Dry Mouth |
1.9% |
|
| Interacting |
| Anxiety |
20.0% |
| Hypertension |
20.0% |
| Intraocular Pressure Increased |
20.0% |
| Panic Attack |
20.0% |
| Prophylaxis |
20.0% |
|
| Drug Interaction |
50.0% |
| Headache |
50.0% |
|
